Seyed Amir Hossein Hamidzadeh , Asal Katebi , Leila Hatami-Giklou Jajan , Farhad Riazi-Rad , Zahra Tavassol , Ava Behrouzi
{"title":"Modulation of cytokine expression by E. coli Nissle 1917 and its OMV in intestinal epithelial cell line HT-29","authors":"Seyed Amir Hossein Hamidzadeh , Asal Katebi , Leila Hatami-Giklou Jajan , Farhad Riazi-Rad , Zahra Tavassol , Ava Behrouzi","doi":"10.1016/j.imbio.2025.153092","DOIUrl":null,"url":null,"abstract":"<div><div>Inflammatory bowel disease (IBD) is a chronic disease recognized as an autoimmune disorder. The purpose of this is to determine the impact of the <em>E. coli</em> strain <em>Nissle 1917</em> (EcN) and its outer membrane vesicles (OMVs) on cytokine gene expression in an IBD cell line model (HT29) in the hope that these effects will guide the development of interventional therapeutic strategies for IBD. First, the cell viability of HT-29 cells treated with EcN and OMVs was evaluated using the MTT assay. Then, inflamed HT29 cells were inoculated with EcN bacteria (multiplicity of infection (MOI) 10, 100), and extracted OMVs (10, 50 μg/ml). Subsequently, cells were harvested for RNA extraction; followed by expression analysis using real-time PCR and also the evaluation of cytokines by ELISA assay. TNF-α, IL-12, and IL-1β mRNA expression was decreased in EcN bacteria (MOI 10 and 100) and OMV 10 μg/ml group. IL-6 mRNA increased in the MOI 100 of ECN group but decreased in OMV μg/ml, despite elevated IL-6 protein levels in the OMV 50 μg/ml. Notably, no detectable secretion of IL-12, TNF-α, or IL-1β was observed in ELISA assays, suggesting post-transcriptional regulation or low sensitivity. The findings revealed that EcN (MOI 10 and 100) enhanced anti-inflammatory IL-10 production, whereas OMV 10 μg/ml showed superior suppression on mRNA level compared to OMV 50 μg/ml.</div></div>","PeriodicalId":13270,"journal":{"name":"Immunobiology","volume":"230 4","pages":"Article 153092"},"PeriodicalIF":2.5000,"publicationDate":"2025-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immunobiology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0171298525002268","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Inflammatory bowel disease (IBD) is a chronic disease recognized as an autoimmune disorder. The purpose of this is to determine the impact of the E. coli strain Nissle 1917 (EcN) and its outer membrane vesicles (OMVs) on cytokine gene expression in an IBD cell line model (HT29) in the hope that these effects will guide the development of interventional therapeutic strategies for IBD. First, the cell viability of HT-29 cells treated with EcN and OMVs was evaluated using the MTT assay. Then, inflamed HT29 cells were inoculated with EcN bacteria (multiplicity of infection (MOI) 10, 100), and extracted OMVs (10, 50 μg/ml). Subsequently, cells were harvested for RNA extraction; followed by expression analysis using real-time PCR and also the evaluation of cytokines by ELISA assay. TNF-α, IL-12, and IL-1β mRNA expression was decreased in EcN bacteria (MOI 10 and 100) and OMV 10 μg/ml group. IL-6 mRNA increased in the MOI 100 of ECN group but decreased in OMV μg/ml, despite elevated IL-6 protein levels in the OMV 50 μg/ml. Notably, no detectable secretion of IL-12, TNF-α, or IL-1β was observed in ELISA assays, suggesting post-transcriptional regulation or low sensitivity. The findings revealed that EcN (MOI 10 and 100) enhanced anti-inflammatory IL-10 production, whereas OMV 10 μg/ml showed superior suppression on mRNA level compared to OMV 50 μg/ml.
期刊介绍:
Immunobiology is a peer-reviewed journal that publishes highly innovative research approaches for a wide range of immunological subjects, including
• Innate Immunity,
• Adaptive Immunity,
• Complement Biology,
• Macrophage and Dendritic Cell Biology,
• Parasite Immunology,
• Tumour Immunology,
• Clinical Immunology,
• Immunogenetics,
• Immunotherapy and
• Immunopathology of infectious, allergic and autoimmune disease.